Inside the adaptation process of Lactobacillus delbrueckii subsp. lactis to bile

International Journal of Food Microbiology
Patricia BurnsClara G de los Reyes-Gavilán

Abstract

Progressive adaptation to bile might render some lactobacilli able to withstand physiological bile salt concentrations. In this work, the adaptation to bile was evaluated on previously isolated dairy strains of Lactobacillus delbrueckii subsp. lactis 200 and L. delbrueckii subsp. lactis 200+, a strain derived thereof with stable bile-resistant phenotype. The adaptation to bile was obtained by comparing cytosolic proteomes of both strains grown in the presence or absence of bile. Proteomics were complemented with physiological studies on both strains focusing on glycolytic end-products, the ability to adhere to the human intestinal epithelial cell line HT29-MTX and survival to simulated gastrointestinal conditions. Protein pattern comparison of strains grown with and without bile allowed us to identify 9 different proteins whose production was regulated by bile in both strains, and 17 proteins that showed differences in their levels between the parental and the bile-resistant derivative. These included general stress response chaperones, proteins involved in transcription and translation, in peptidoglycan/exopolysaccharide biosynthesis, in the lipid and nucleotide metabolism and several glycolytic and pyruvate catabolism enzymes...Continue Reading

Citations

Nov 17, 2010·Molecular & Cellular Proteomics : MCP·Kerttu KoskenniemiPekka Varmanen
Jan 29, 2013·Applied and Environmental Microbiology·Quirin SinzWilfried Schwab
Aug 1, 2013·Canadian Journal of Microbiology·Shigenori SuzukiNobuhiro Yajima
May 18, 2013·Microbial Cell Factories·Michelle M O'DonnellReynolds Paul Ross
Apr 28, 2012·Current Opinion in Microbiology·Rosa Anna Siciliano, Maria Fiorella Mazzeo
Apr 23, 2013·Journal of Applied Microbiology·A BinettiV Suárez
Mar 24, 2016·Journal of Proteomics·Lorena RuizAbelardo Margolles
Mar 24, 2016·Proteomics·Maria De AngelisMarco Gobbetti
Aug 15, 2015·Anaerobe·Hiromi Kimoto-NiraChise Suzuki
Feb 11, 2012·Microbiology·Cristina Alcántara, Manuel Zúñiga
May 12, 2015·Canadian Journal of Microbiology·Magdaléna SlížováJuraj Pistl
Mar 19, 2019·Critical Reviews in Food Science and Nutrition·Daniela FioccoVittorio Capozzi
Feb 20, 2019·Current Microbiology·Paul Priyodip, Seetharaman Balaji
Dec 18, 2020·Comprehensive Reviews in Food Science and Food Safety·Mustapha MbyeMutamed M Ayyash
Apr 4, 2021·Animals : an Open Access Journal From MDPI·Marta DecRenata Urban-Chmiel
Nov 2, 2011·Journal of Proteome Research·Erwann HamonSaïd Ennahar

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Bacterial Cell Wall Structure

Bacterial cell walls are made of peptidoglycan (also called murein), which is made from polysaccharide chains cross-linked by unusual peptides containing D-amino acids. Here is the latest research on bacterial cell wall structures.

Bacterial Cell Wall Structure (ASM)

Bacterial cell walls are made of peptidoglycan (also called murein), which is made from polysaccharide chains cross-linked by unusual peptides containing D-amino acids. Here is the latest research on bacterial cell wall structures.

Aminoglycosides

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Aminoglycosides (ASM)

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.